{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T09:59:47Z","timestamp":1770717587207,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010653","name":"Masarykova Univerzita","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.psyneuen.2016.07.218","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T07:27:05Z","timestamp":1469777225000},"page":"177-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats"],"prefix":"10.1016","volume":"73","author":[{"given":"Katerina","family":"Horska","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jana","family":"Ruda-Kucerova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zuzana","family":"Babinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Karpisek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Demlova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radka","family":"Opatrilova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Suchy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hana","family":"Kotolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2016.07.218_bib0005","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/oby.2006.6","article-title":"Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents","volume":"14","author":"Albaugh","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/mp.2010.33","article-title":"Olanzapine promotes fat accumulation in male rats by decreasing physical activity, repartitioning energy and increasing adipose tissue lipogenesis while impairing lipolysis","volume":"16","author":"Albaugh","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0015","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2337\/diabetes.52.2.252","article-title":"Role of leptin in the regulation of glucagon-like peptide-1 secretion","volume":"52","author":"Anini","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0020","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2337\/diabetes.53.5.1253","article-title":"Triglycerides induce leptin resistance at the blood-brain barrier","volume":"53","author":"Banks","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0025","doi-asserted-by":"crossref","first-page":"e25537","DOI":"10.1371\/journal.pone.0025537","article-title":"Dopamine receptors in human adipocytes: expression and functions","volume":"6","author":"Borcherding","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0030","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tips.2010.07.002","article-title":"Preclinical models of antipsychotic drug-induced metabolic side effects","volume":"31","author":"Boyda","year":"2010","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0035","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1194\/jlr.M026948","article-title":"Atypical antipsychotics alter cholesterol and fatty acid metabolism in vitro","volume":"54","author":"Canfran-Duque","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0040","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.molmed.2010.10.010","article-title":"Antipsychotic drugs and obesity","volume":"17","author":"Correll","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1096\/fasebj.28.1_supplement.1107.5","article-title":"Dopamine D2 receptors regulate leptin and IL-6 in 3T3 L1 adipocytes (1107.5)","volume":"28","author":"Cuevas","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0050","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","article-title":"Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters","volume":"221","author":"Davey","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0055","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00213-008-1415-1","article-title":"Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine","volume":"203","author":"Davoodi","year":"2009","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0060","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"De Hert","year":"2012","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0065","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00210-013-0933-5","article-title":"Chronic treatment with olanzapine increases adiposity by changing fuel substrate and causes desensitization of the acute metabolic side effects","volume":"387","author":"Girault","year":"2014","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0070","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1177\/0269881115602952","article-title":"Effect of long-term olanzapine treatment on meal-induced insulin sensitization and on gastrointestinal peptides in female Sprague-Dawley rats","volume":"29","author":"Hegedus","year":"2015","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0075","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00213-011-2397-y","article-title":"Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat","volume":"219","author":"Jassim","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.peptides.2007.10.017","article-title":"Central leptin insufficiency syndrome: an interactive etiology for obesity, metabolic and neural diseases and for designing new therapeutic interventions","volume":"29","author":"Kalra","year":"2008","journal-title":"Peptides"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0085","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1176\/appi.ajp.2009.07081221","article-title":"Olanzapine long-acting injection: a 24-week, randomized, double-blind trial of maintenance treatment in patients with schizophrenia","volume":"167","author":"Kane","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0090","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0095","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.coph.2009.07.001","article-title":"FGFs and metabolism","volume":"9","author":"Kharitonenkov","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1467-789X.2006.00270.x","article-title":"The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review","volume":"8","author":"Klok","year":"2007","journal-title":"Obes. Rev."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0105","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00210-015-1091-8","article-title":"Meal-induced insulin sensitization is preserved after acute olanzapine administration in female Sprague-Dawley rats","volume":"388","author":"Kovacs","year":"2015","journal-title":"Naunyn. Schmiedebergs Arch. Pharmacol."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0110","doi-asserted-by":"crossref","first-page":"208","DOI":"10.5507\/bp.2014.060","article-title":"The common pathophysiology underlying the metabolic syndrome, schizophrenia and depression. A review","volume":"159","author":"Kucerova","year":"2015","journal-title":"Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech Repub."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1600-0447.2007.01095.x","article-title":"Physical illness and schizophrenia: a review of the literature","volume":"116","author":"Leucht","year":"2007","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0120","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(13)60733-3","article-title":"Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis","volume":"382","author":"Leucht","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0125","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pharmthera.2011.06.003","article-title":"Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative\/cognitive symptoms and beyond","volume":"132","author":"Meyer","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0130","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/sj.mp.4001948","article-title":"Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment","volume":"12","author":"Minet-Ringuet","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0135","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/schbul\/sbr148","article-title":"Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders\u2013a systematic review and meta-analysis","volume":"39","author":"Mitchell","year":"2013","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0140","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1097\/00004714-200208000-00015","article-title":"Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment","volume":"22","author":"Monteleone","year":"2002","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0145","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.molmet.2015.03.005","volume":"4","author":"Muller","year":"2015","journal-title":"Ghrelin Mol. Metab."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0150","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol. Psychiatry"},{"issue":"Suppl. 1","key":"10.1016\/j.psyneuen.2016.07.218_bib0155","first-page":"20","article-title":"Metabolic considerations in the use of antipsychotic medications: a review of recent evidence","volume":"68","author":"Newcomer","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0160","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.1038\/nutd.2011.21","article-title":"Appetite regulation and weight control: the role of gut hormones","volume":"2","author":"Perry","year":"2012","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0165","first-page":"S26","article-title":"Antipsychotic-induced changes in blood levels of leptin in schizophrenia: a meta-analysis","volume":"60","author":"Potvin","year":"2015","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0170","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3945\/jn.114.206029","article-title":"Glucagon-like peptide 1 interacts with ghrelin and leptin to regulate glucose metabolism and food intake through vagal afferent neuron signaling","volume":"145","author":"Ronveaux","year":"2015","journal-title":"J. Nutr."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0175","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1093\/schbul\/sbm141","article-title":"Leptin and ghrelin levels in patients with schizophrenia during different antipsychotics treatment: a review","volume":"34","author":"Sentissi","year":"2008","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0180","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.4088\/JCP.08r04392","article-title":"Are weight gain and metabolic side effects of atypical antipsychotics dose dependent? A literature review","volume":"70","author":"Simon","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0185","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S1461145711001271","article-title":"Olanzapine, but not aripiprazole, weight-independently elevates serum triglycerides and activates lipogenic gene expression in female rats","volume":"15","author":"Skrede","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0190","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1194\/jlr.E034736","article-title":"Antipsychotic-induced increase in lipid biosynthesis: activation through inhibition","volume":"54","author":"Skrede","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0195","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1017\/S1461145713000862","article-title":"Olanzapine depot formulation in rat: a step forward in modelling antipsychotic-induced metabolic adverse effects","volume":"17","author":"Skrede","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0200","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.psyneuen.2015.09.026","article-title":"Are leptin levels increased among people with schizophrenia versus controls? A systematic review and comparative meta-analysis","volume":"63","author":"Stubbs","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0205","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.pnpbp.2010.06.002","article-title":"Induction of subcutaneous adipose proliferation by olanzapine in rodents","volume":"34","author":"Tan","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0210","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.pbb.2010.05.009","article-title":"Olanzapine affects locomotor activity and meal size in male rats","volume":"97","author":"van der Zwaal","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0215","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/ijo.2011.97","article-title":"The acute effects of olanzapine on ghrelin secretion, CCK sensitivity, meal size, locomotor activity and body temperature","volume":"36","author":"van der Zwaal","year":"2012","journal-title":"Int. J. Obes. (Lond.)"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0220","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1017\/S146114571300093X","article-title":"Modelling olanzapine-induced weight gain in rats","volume":"17","author":"van der Zwaal","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0225","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.brainres.2010.05.060","article-title":"Olanzapine-induced accumulation of adipose tissue is associated with an inflammatory state","volume":"1350","author":"Victoriano","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0230","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0053-14.2015","article-title":"Growth hormone secretagogue receptor dimers: a new pharmacological target (1,2,3)","volume":"2","author":"Wellman","year":"2015","journal-title":"eNeuro"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0235","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbr.2010.10.039","article-title":"Olanzapine treatment and metabolic dysfunction: a dose response study in female Sprague Dawley rats","volume":"217","author":"Weston-Green","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0240","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.psyneuen.2014.11.013","article-title":"Ghrelin in psychiatric disorders \u2013 a review","volume":"52","author":"Wittekind","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00213-013-3193-7","article-title":"Potential mechanisms of atypical antipsychotic-induced hypertriglyceridemia","volume":"229","author":"Yan","year":"2013","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0250","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0255","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/j.psyneuen.2013.07.010","article-title":"The role of ghrelin signalling in second-generation antipsychotic-induced weight gain","volume":"38","author":"Zhang","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0260","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.pnpbp.2014.02.003","article-title":"Olanzapine reduced brown adipose tissue thermogenesis and locomotor activity in female rats","volume":"51","author":"Zhang","year":"2014","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psyneuen.2016.07.218_bib0265","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1590\/S1516-44462012000200009","article-title":"Energy metabolism, leptin, and biochemical parameters are altered in rats subjected to the chronic administration of olanzapine","volume":"34","author":"Zugno","year":"2012","journal-title":"Rev. Bras. Psiquiatr."}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016304930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453016304930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:55:12Z","timestamp":1759683312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453016304930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":53,"alternative-id":["S0306453016304930"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2016.07.218","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Olanzapine-depot administration induces time-dependent changes in adipose tissue endocrine function in rats","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2016.07.218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}